FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
International journal of molecular sciences2024; 25(21); doi: 10.3390/ijms252111513

Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4+ T Cells of an Autoimmune Uveitis Model.

Abstract: Equine recurrent uveitis (ERU) is a spontaneously occurring autoimmune disease and one of the leading causes of blindness in horses worldwide. Its similarities to autoimmune-mediated uveitis in humans make it a unique spontaneous animal model for this disease. Although many aspects of ERU pathogenesis have been elucidated, it remains not fully understood and requires further research. CD4+ T cells have been a particular focus of research. In a previous study, we showed metabolic alterations in CD4+ T cells from ERU cases, including an increased basal oxygen consumption rate (OCR) and elevated compensatory glycolysis. To further investigate the underlying reasons for and consequences of these metabolic changes, we quantified reactive oxygen species (ROS) production in CD4+ T cells from ERU cases and compared it to healthy controls, revealing significantly higher ROS production in ERU-affected horses. Additionally, we aimed to define mitochondrial fuel oxidation of glucose, glutamine, and long-chain fatty acids (LCFAs) and identified significant differences between CD4+ T cells from ERU cases and controls. CD4+ T cells from ERU cases showed a lower dependency on mitochondrial glucose oxidation and greater metabolic flexibility for the mitochondrial oxidation of glucose and LCFAs, indicating an enhanced ability to switch to alternative fuels when necessary.
Get Full Text
Publication Date: 2024-10-26 PubMed ID: 39519064PubMed Central: PMC11545935DOI: 10.3390/ijms252111513Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explores the elevated occurrence of an inflammatory eye disease called equine recurrent uveitis (ERU) in horses, with a particular focus on the metabolic alterations in CD4+ T cells, a type of immune cell. The researchers found higher production of reactive oxygen species (ROS) in diseased horses, as well as significant changes in their cells’ use of different metabolic fuels, suggesting that these changes may play a part in ERU occurrence.

Study Context

  • The research is aimed at understanding the pathogenesis of equine recurrent uveitis (ERU), an autoimmune disease in horses that often leads to blindness.
  • ERU shares similarities with human autoimmune-mediated uveitis, hence why the discoveries made in this type of research can potentially aid in the understanding and treatment of the human condition.
  • Despite previous research, the pathogenesis of ERU is not yet completely understood, and this study contributes to that ongoing investigation.

Role of CD4 T Cells in ERU

  • The authors have previously identified metabolic changes in the CD4 T cells of horses with ERU, including increased basal oxygen consumption rate (OCR), and raised compensatory glycolysis.
  • CD4 T cells are vital in the immune response, hence understanding their role and behavior is crucial when investigating an autoimmune disease like ERU.

Increased ROS Production

  • In this paper, it is reported that CD4 T cells from ERU-affected horses produce a significantly higher amount of reactive oxygen species (ROS) when compared to healthy controls.
  • ROS are chemically reactive molecules that play roles in cell signaling and homeostasis. High levels can be damaging, and this may be linked to the disease progression.

Mitochondrial Metabolic Shifts

  • Investigating the mitochondrial fuel oxidation of glucose, glutamine, and long-chain fatty acids (LCFAs), the study reports significant differences in the CD4 T cells of ERU-affected and healthy horses.
  • CD4 T cells from ERU cases showed less reliance on mitochondrial glucose oxidation and higher metabolic versatility when oxidizing glucose and LCFAs.
  • This greater ability to switch to alternative fuels when needed (metabolic flexibility) could be a response to physiological changes brought about by the disease or a contributing factor to its onset.

Cite This Article

APA
Söth R, Hoffmann ALC, Deeg CA. (2024). Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4+ T Cells of an Autoimmune Uveitis Model. Int J Mol Sci, 25(21). https://doi.org/10.3390/ijms252111513

Publication

International journal of molecular sciences
ISSN: 1422-0067
NlmUniqueID: 101092791
Country: Switzerland
Language: English
Volume: 25
Issue: 21

Researcher Affiliations

Söth, Ronja
  • Chair of Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany.
Hoffmann, Anne L C
  • Chair of Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany.
Deeg, Cornelia A
  • Chair of Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany.

MeSH Terms

  • Animals
  • Reactive Oxygen Species / metabolism
  • Uveitis / metabolism
  • Uveitis / veterinary
  • Uveitis / immunology
  • Uveitis / pathology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / immunology
  • Horses
  • Mitochondria / metabolism
  • Autoimmune Diseases / metabolism
  • Autoimmune Diseases / immunology
  • Disease Models, Animal
  • Glucose / metabolism
  • Horse Diseases / metabolism
  • Horse Diseases / immunology
  • Glycolysis
  • Oxygen Consumption
  • Fatty Acids / metabolism
  • Oxidation-Reduction

Grant Funding

  • DFG DE 719/4-4 / Deutsche Forschungsgemeinschaft

Conflict of Interest Statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

This article includes 90 references
  1. Noble J, Macek Jilkova Z, Aspord C, Malvezzi P, Fribourg M, Riella LV, Cravedi P. Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation.. Transpl. Int. 2024;37:12330.
    doi: 10.3389/ti.2024.12330pmc: PMC10985621pubmed: 38567143google scholar: lookup
  2. Wu HA-O, Zhao X, Hochrein SM, Eckstein M, Gubert GA-OX, Knöpper KA-O, Mansilla AM, Öner A, Doucet-Ladevèze R, Schmitz WA-O. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming.. Nat. Commun. 2023;14:6858.
    doi: 10.1038/s41467-023-42634-3pmc: PMC10611730pubmed: 37891230google scholar: lookup
  3. Shang E, Nguyen TTT, Westhoff MA, Karpel-Massler G, Siegelin MD. Targeting cellular respiration as a therapeutic strategy in glioblastoma.. Oncotarget 2023;14:419–425.
    doi: 10.18632/oncotarget.28424pmc: PMC10159369pubmed: 37141415google scholar: lookup
  4. Warburg O. On the origin of cancer cells.. Science 1956;123:309–314.
    doi: 10.1126/science.123.3191.309pubmed: 13298683google scholar: lookup
  5. Tang X, Mao X, Ling P, Yu M, Pan H, Wang J, Liu M, Pan H, Qiu W, Che N. Glycolysis inhibition induces anti-tumor central memory CD8(+)T cell differentiation upon combination with microwave ablation therapy.. Nat. Commun. 2024;15:4665.
    doi: 10.1038/s41467-024-49059-6pmc: PMC11143264pubmed: 38821965google scholar: lookup
  6. Yang WA-O, Yu T, Cong YA-O. CD4(+) T cell metabolism, gut microbiota, and autoimmune diseases: Implication in precision medicine of autoimmune diseases.. Precis. Clin. Med. 2022;5:pbac018.
    doi: 10.1093/pcmedi/pbac018pmc: PMC9384833pubmed: 35990897google scholar: lookup
  7. Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F, Gerecke C, Rosenfeldt M, Grün D, Kleuser B. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.. Cell Metab. 2022;34:516–532.
    doi: 10.1016/j.cmet.2022.02.015pmc: PMC9019065pubmed: 35316657google scholar: lookup
  8. Muri J, Kopf M. Redox regulation of immunometabolism.. Nat. Rev. Immunol. 2021;21:363–381.
    doi: 10.1038/s41577-020-00478-8pubmed: 33340021google scholar: lookup
  9. Macintyre AN, Gerriets VA, Nichols AG, Michalek RD, Rudolph MC, Deoliveira D, Anderson SM, Abel ED, Chen BJ, Hale LP. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.. Cell Metab. 2014;20:61–72.
    doi: 10.1016/j.cmet.2014.05.004pmc: PMC4079750pubmed: 24930970google scholar: lookup
  10. Ma S, Ming Y, Wu J, Cui G. Cellular metabolism regulates the differentiation and function of T-cell subsets.. Cell Mol. Immunol. 2024;21:419–435.
    doi: 10.1038/s41423-024-01148-8pmc: PMC11061161pubmed: 38565887google scholar: lookup
  11. Gülow K, Tümen D, Heumann P, Schmid S, Kandulski A, Müller M, Kunst C. Unraveling the Role of Reactive Oxygen Species in T Lymphocyte Signaling.. Int. J. Mol. Sci. 2024;25:6114.
    doi: 10.3390/ijms25116114pmc: PMC11172744pubmed: 38892300google scholar: lookup
  12. Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement.. Redox Biol. 2020;37:101674.
    doi: 10.1016/j.redox.2020.101674pmc: PMC7767752pubmed: 32811789google scholar: lookup
  13. Chang CH, Curtis JD, Maggi LB, Faubert B, Villarino AV, O’Sullivan D, Huang SC-CC, van der Windt GJW, Blagih J, Qiu J. Posttranscriptional control of T cell effector function by aerobic glycolysis.. Cell 2013;153:1239–1251.
    doi: 10.1016/j.cell.2013.05.016pmc: PMC3804311pubmed: 23746840google scholar: lookup
  14. Maduka CV, Kuhnert MM, Habeeb OM, Tundo A, Makela AV, Goodman SB, Contag CH. Elevated oxidative phosphorylation is critical for immune cell activation by polyethylene wear particles.. J. Immunol. Regen. Med. 2023;19:100069.
    doi: 10.1016/j.regen.2022.100069google scholar: lookup
  15. Shu P, Liang H, Zhang J, Lin Y, Chen W, Zhang D. Reactive oxygen species formation and its effect on CD4(+) T cell-mediated inflammation.. Front. Immunol. 2023;14:1199233.
    doi: 10.3389/fimmu.2023.1199233pmc: PMC10249013pubmed: 37304262google scholar: lookup
  16. Starkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, Patel MS, Beal MF. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species.. J. Neurosci. 2004;24:7779–7788.
    doi: 10.1523/JNEUROSCI.1899-04.2004pmc: PMC6729932pubmed: 15356189google scholar: lookup
  17. Long DL, McCall CE, Poole LB. Glutathionylation of pyruvate dehydrogenase complex E2 and inflammatory cytokine production during acute inflammation are magnified by mitochondrial oxidative stress.. Redox Biol. 2023;65:102841.
    doi: 10.1016/j.redox.2023.102841pmc: PMC10440583pubmed: 37566945google scholar: lookup
  18. Liu Y, Chen W, Li C, Li L, Yang M, Jiang N, Luo S, Xi Y, Liu C, Han Y. DsbA-L interacting with catalase in peroxisome improves tubular oxidative damage in diabetic nephropathy.. Redox Biol. 2023;66:102855.
    doi: 10.1016/j.redox.2023.102855pmc: PMC10458997pubmed: 37597421google scholar: lookup
  19. Diaz JM, Shi X. NOX-like ROS production by glutathione reductase.. iScience 2022;25:105093.
    doi: 10.1016/j.isci.2022.105093pmc: PMC9519596pubmed: 36185373google scholar: lookup
  20. Kowalczyk P, Sulejczak D, Kleczkowska P, Bukowska-Osko I, Kucia M, Popiel M, Wietrak E, Kramkowski K, Wrzosek K, Kaczynska K. Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases.. Int. J. Mol. Sci. 2021;22:13384.
    doi: 10.3390/ijms222413384pmc: PMC8707347pubmed: 34948180google scholar: lookup
  21. Wang L, Lu Z, Zhao J, Schank M, Cao D, Dang X, Nguyen LN, Nguyen LNT, Khanal S, Zhang J. Selective oxidative stress induces dual damage to telomeres and mitochondria in human T cells.. Aging Cell 2021;20:e13513.
    doi: 10.1111/acel.13513pmc: PMC8672791pubmed: 34752684google scholar: lookup
  22. Abad C, Pinal-Fernandez I, Guillou C, Bourdenet G, Drouot L, Cosette P, Giannini M, Debrut L, Jean L, Bernard S. IFNγ causes mitochondrial dysfunction and oxidative stress in myositis.. Nat. Commun. 2024;15:5403.
    doi: 10.1038/s41467-024-49460-1pmc: PMC11208592pubmed: 38926363google scholar: lookup
  23. Zhang Z, Cheng B, Du W, Zeng M, He K, Yin T, Shang S, Su T, Han D, Gan X. The Role of Nicotinamide Mononucleotide Supplementation in Psoriasis Treatment.. Antioxidants 2024;13:186.
    doi: 10.3390/antiox13020186pmc: PMC10886094pubmed: 38397784google scholar: lookup
  24. Huang J, Wang X, Li N, Fan W, Li X, Zhou Q, Liu J, Li W, Zhang Z, Liu X. YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes.. Adv. Sci. 2024;11:2470110.
    doi: 10.1002/advs.202470110pmc: PMC11109619pubmed: 38493498google scholar: lookup
  25. Zhang M, Zhang X. T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches.. Int. Immunopharmacol. 2023;114:109565.
    doi: 10.1016/j.intimp.2022.109565pubmed: 36535124google scholar: lookup
  26. Zhang C, Liu X, Xiao J, Jiang F, Fa L, Jiang H, Zhou L, Su W, Xu Z. γδ T cells in autoimmune uveitis pathogenesis: A promising therapeutic target.. Biochem. Pharmacol. 2023;213:115629.
    doi: 10.1016/j.bcp.2023.115629pubmed: 37257721google scholar: lookup
  27. Chen YH, Eskandarpour M, Zhang X, Galatowicz G, Greenwood J, Lightman S, Calder VA-O. Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis.. J. Neuroinflamm. 2021;18:49.
    doi: 10.1186/s12974-021-02080-8pmc: PMC7893745pubmed: 33602234google scholar: lookup
  28. Sharma M, Pal P, Gupta SK. Microglial mediators in autoimmune Uveitis: Bridging neuroprotection and neurotoxicity.. Int. Immunopharmacol. 2024;136:112309.
    doi: 10.1016/j.intimp.2024.112309pubmed: 38810304google scholar: lookup
  29. Hoffmann ALC, Hauck SM, Deeg CA, Degroote RL. Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro.. Int. J. Mol. Sci. 2022;23:9555.
    doi: 10.3390/ijms23179555pmc: PMC9455241pubmed: 36076947google scholar: lookup
  30. Degroote RL, Schmalen A, Hauck SM, Deeg CA. Unveiling Differential Responses of Granulocytes to Distinct Immunostimulants with Implications in Autoimmune Uveitis.. Biomedicines 2024;12:19.
    doi: 10.3390/biomedicines12010019pmc: PMC10812922pubmed: 38275380google scholar: lookup
  31. Deeg CA, Kaspers B, Gerhards H, Thurau SR, Wollanke B, Wildner G. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis.. Investig. Ophthalmol. Vis. Sci. 2001;42:393–398.
    pubmed: 11157872
  32. Kingsley NA-O, Sandmeyer LA-O, Bellone RA-O. A review of investigated risk factors for developing equine recurrent uveitis.. Vet. Ophthalmol. 2022;26:86–100.
    doi: 10.1111/vop.13002pubmed: 35691017google scholar: lookup
  33. Malalana F, Stylianides A, McGowan C. Equine recurrent uveitis: Human and equine perspectives.. Vet. J. 2015;206:22–29.
    doi: 10.1016/j.tvjl.2015.06.017pubmed: 26188862google scholar: lookup
  34. Deeg CA, Hauck SM, Amann B, Pompetzki D, Altmann F, Raith A, Schmalzl T, Stangassinger M, Ueffing M. Equine recurrent uveitis--a spontaneous horse model of uveitis.. Ophthalmic Res. 2008;40:151–153.
    doi: 10.1159/000119867pubmed: 18421230google scholar: lookup
  35. Barfusser C, Wiedemann C, Hoffmann ALC, Hirmer S, Deeg CA. Altered Metabolic Phenotype of Immune Cells in a Spontaneous Autoimmune Uveitis Model.. Front. Immunol. 2021;12:601619.
    doi: 10.3389/fimmu.2021.601619pmc: PMC8353246pubmed: 34385998google scholar: lookup
  36. Mellstedt H. In vitro activation of human T and B lymphocytes by pokeweed mitogen.. Clin. Exp. Immunol. 1975;19:75.
    pmc: PMC1538036pubmed: 1081926
  37. Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, Wang CR, Schumacker PT, Licht JD, Perlman H. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.. Immunity 2013;38:225–236.
    doi: 10.1016/j.immuni.2012.10.020pmc: PMC3582741pubmed: 23415911google scholar: lookup
  38. Schank M, Zhao J, Wang L, Nguyen LN, Zhang Y, Wu XY, Zhang J, Jiang Y, Ning S, El Gazzar M. ROS-Induced Mitochondrial Dysfunction in CD4 T Cells from ART-Controlled People Living with HIV.. Viruses 2023;15.
    doi: 10.3390/v15051061pmc: PMC10224005pubmed: 37243148google scholar: lookup
  39. Schlaepfer IR, Joshi M. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.. Endocrinology 2020;161:bqz046.
    doi: 10.1210/endocr/bqz046pubmed: 31900483google scholar: lookup
  40. Horohov DW. The equine immune responses to infectious and allergic disease: A model for humans?. Mol. Immunol. 2015;66:89–96.
    doi: 10.1016/j.molimm.2014.09.020pubmed: 25457878google scholar: lookup
  41. Wincup C, Wilkinson M, Radziszewska A, Robinson G, Rahman A. POS0295 CD4+ T cells demonstrate metabolic reprogramming characterised by increased reactive oxygen species formation and enhanced atp generation in systemic lupus erythematosus.. Ann. Rheum. Dis. 2023;82:389.
    doi: 10.1136/annrheumdis-2023-eular.6118google scholar: lookup
  42. Wojtala A, Bonora M, Malinska D, Pinton P, Duszynski J, Wieckowski MR. Chapter Thirteen—Methods to Monitor ROS Production by Fluorescence Microscopy and Fluorometry.. Methods in Enzymology 2014;542:243–262.
    pubmed: 24862270
  43. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation.. Nat. Immunol. 2004;5:818–827.
    doi: 10.1038/ni1096pubmed: 15258578google scholar: lookup
  44. Kaminski M, Kießling M, Süss D, Krammer PH, Gülow K. Novel role for mitochondria: Protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death.. Mol. Cell Biol. 2007;27:3625–3639.
    doi: 10.1128/MCB.02295-06pmc: PMC1900004pubmed: 17339328google scholar: lookup
  45. de Haan LR, Reiniers MJ, Reeskamp LF, Belkouz A, Ao L, Cheng S, Ding B, van Golen RF, Heger M. Experimental Conditions That Influence the Utility of 2′7′-Dichlorodihydrofluorescein Diacetate (DCFH2-DA) as a Fluorogenic Biosensor for Mitochondrial Redox Status.. Antioxidants 2022;11:1424.
    doi: 10.3390/antiox11081424pmc: PMC9329753pubmed: 35892626google scholar: lookup
  46. Lee C, Nam JS, Lee CG, Park M, Yoo CM, Rhee HW, Seo JK, Kwon TH. Analysing the mechanism of mitochondrial oxidation-induced cell death using a multifunctional iridium(III) photosensitiser.. Nat. Commun. 2021;12:26.
    doi: 10.1038/s41467-020-20210-3pmc: PMC7782791pubmed: 33397915google scholar: lookup
  47. Lin W, Shen P, Song Y, Huang Y, Tu S. Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism.. Front. Immunol. 2021;12:635021.
    doi: 10.3389/fimmu.2021.635021pmc: PMC7946999pubmed: 33717180google scholar: lookup
  48. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.. EMBO J. 1991;10:2247–2258.
    doi: 10.1002/j.1460-2075.1991.tb07761.xpmc: PMC452914pubmed: 2065663google scholar: lookup
  49. Padgett LE, Tse HM. NADPH Oxidase-Derived Superoxide Provides a Third Signal for CD4 T Cell Effector Responses.. J. Immunol. 2016;197:1733–1742.
    doi: 10.4049/jimmunol.1502581pmc: PMC4992601pubmed: 27474077google scholar: lookup
  50. Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.. Vet. Ophthalmol. 2020;23:160–170.
    doi: 10.1111/vop.12704pmc: PMC6980227pubmed: 31441218google scholar: lookup
  51. Jiang R, Zhou H, Kong X, Zhou Z. Reactive Oxygen Species Modulate Th17/Treg Balance in Chlamydia psittaci Pneumonia via NLRP3/IL-1β/Caspase-1 Pathway Differentiation.. Folia Biol. 2024;70:74.
    doi: 10.14712/fb2024070010074pubmed: 38830125google scholar: lookup
  52. Ma JG, Wu GJ, Xiao HL, Xiao YM, Zha LA-O. Vitamin D has an effect on airway inflammation and Th17/Treg balance in asthmatic mice.. Kaohsiung J. Med. Sci. 2021;37:1113–1121.
    doi: 10.1002/kjm2.12441pmc: PMC11896363pubmed: 34460994google scholar: lookup
  53. Xie Y, Deng Q, Guo M, Li X, Xian D, Zhong J. Proanthocyanidins: A novel approach to Henoch-Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF-κB signaling pathway (Review). Exp. Ther. Med. 2023;25:300.
    doi: 10.3892/etm.2023.11999pmc: PMC10203752pubmed: 37229322google scholar: lookup
  54. Murdaca G, Colombo BM, Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases.. Intern. Emerg. Med. 2011;6:487–495.
    doi: 10.1007/s11739-011-0517-7pubmed: 21258875google scholar: lookup
  55. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.. J. Immunol. 2000;164:2832–2838.
    doi: 10.4049/jimmunol.164.5.2832pubmed: 10679127google scholar: lookup
  56. Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, Kyttaris VC, Juang Y-T, Tsokos GC. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.. J. Immunol. 2008;181:8761–8766.
    doi: 10.4049/jimmunol.181.12.8761pmc: PMC2596652pubmed: 19050297google scholar: lookup
  57. Regan DP, Aarnio MC, Davis WS, Carmichael KP, Vandenplas ML, Lauderdale JD, Moore PA. Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis.. Vet. Ophthalmol. 2012;15:145–152.
    doi: 10.1111/j.1463-5224.2011.00951.xpubmed: 22051225google scholar: lookup
  58. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan C-C, Caspi RR. Either a Th17 or a Th1 effector response can drive autoimmunity: Conditions of disease induction affect dominant effector category.. J. Exp. Med. 2008;205:799–810.
    doi: 10.1084/jem.20071258pmc: PMC2292220pubmed: 18391061google scholar: lookup
  59. Ruggieri S, Frassanito MA, Dammacco R, Guerriero S. Treg lymphocytes in autoimmune uveitis.. Ocul. Immunol. Inflamm. 2012;20:255–261.
    doi: 10.3109/09273948.2012.681830pubmed: 22564107google scholar: lookup
  60. Yeh S, Li Z, Forooghian F, Hwang FS, Cunningham MA, Pantanelli S, Nussenblatt RB. CD4+Foxp3+ T-regulatory cells in noninfectious uveitis.. Ocul. Immunol. Inflamm. 2009;127:407–413.
    doi: 10.1001/archophthalmol.2009.32pmc: PMC2928652pubmed: 19365016google scholar: lookup
  61. Degroote RL, Deeg CA. Immunological Insights in Equine Recurrent Uveitis.. Front. Immunol. 2020;11:609855.
    doi: 10.3389/fimmu.2020.609855pmc: PMC7821741pubmed: 33488614google scholar: lookup
  62. Murdaca G, Greco M, Tonacci A, Negrini S, Borro M, Puppo F, Gangemi S. IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases.. Int. J. Mol. Sci. 2019;20:5856.
    doi: 10.3390/ijms20235856pmc: PMC6929191pubmed: 31766607google scholar: lookup
  63. Li P, Lin W, Zheng X. IL-33 Neutralization Suppresses Lupus Disease in Lupus-Prone Mice.. Inflammation 2014;37:824–832.
    doi: 10.1007/s10753-013-9802-0pubmed: 24398614google scholar: lookup
  64. Barbour M, Allan D, Xu H, Pei C, Chen M, Niedbala W, Fukada SY, Besnard A-G, Alves-Filho JC, Tong X. IL-33 attenuates the development of experimental autoimmune uveitis.. Eur. J. Immunol. 2014;44:3320–3329.
    doi: 10.1002/eji.201444671pmc: PMC4449115pubmed: 25116404google scholar: lookup
  65. Lin Q, Li K, Chen Y, Xie J, Wu C, Cui C, Deng BA-O. Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment.. Mol. Neurobiol. 2023;60:4574–4594.
    doi: 10.1007/s12035-023-03342-7pubmed: 37115404google scholar: lookup
  66. Jiang Z, Liang K, Gao X, Cao F, An G, Gui S, Tang W, Du L, Tao L, Wang XA-OX. Fe-curcumin nanozyme-mediated immunosuppression and anti-inflammation in experimental autoimmune uveitis.. Biomater. Res. 2023;27:131.
    doi: 10.1186/s40824-023-00451-1pmc: PMC10717250pubmed: 38087367google scholar: lookup
  67. Ung L, Pattamatta U, Carnt N, Wilkinson-Berka JL, Liew G, White AJR. Oxidative stress and reactive oxygen species: A review of their role in ocular disease.. Clin. Sci. 2017;131:2865–2883.
    doi: 10.1042/CS20171246pubmed: 29203723google scholar: lookup
  68. Hsu S-M, Yang C-H, Teng Y-T, Tsai H-Y, Lin C-Y, Lin C-J, Shieh C-C, Chen S-H. Suppression of the Reactive Oxygen Response Alleviates Experimental Autoimmune Uveitis in Mice.. Int. J. Mol. Sci. 2020;21.
    doi: 10.3390/ijms21093261pmc: PMC7247341pubmed: 32380695google scholar: lookup
  69. Moradi Vastegani S, Nasrolahi A, Ghaderi S, Belali R, Rashno M, Farzaneh M, Khoshnam SE. Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies.. Neurochem. Res. 2023;48:2285–2308.
    doi: 10.1007/s11064-023-03904-0pubmed: 36943668google scholar: lookup
  70. Zong Y, Li H, Liao PA-O, Chen L, Pan Y, Zheng Y, Zhang C, Liu D, Zheng MA-O, Gao JA-O. Mitochondrial dysfunction: Mechanisms and advances in therapy.. Nature 2024;9:124.
    doi: 10.1038/s41392-024-01839-8pmc: PMC11094169pubmed: 38744846google scholar: lookup
  71. Chakrabarti RA-O, Fung TA-O, Kang TA-OX, Elonkirjo PW, Suomalainen AA-O, Usherwood EA-O, Higgs HA-O. Mitochondrial dysfunction triggers actin polymerization necessary for rapid glycolytic activation.. J. Cell Biol. 2022;221:e202201160.
    doi: 10.1083/jcb.202201160pmc: PMC9477750pubmed: 36102863google scholar: lookup
  72. Psarras A, Clarke A. A cellular overview of immunometabolism in systemic lupus erythematosus.. Oxf. Open Immunol. 2023;4:iqad005.
    doi: 10.1093/oxfimm/iqad005pmc: PMC10264559pubmed: 37554724google scholar: lookup
  73. Xu Y, Li M, Lin M, Cui D, Xie J. Glutaminolysis of CD4(+) T Cells: A Potential Therapeutic Target in Viral Diseases.. J. Inflamm. Res. 2024;17:603–616.
    doi: 10.2147/JIR.S443482pmc: PMC10840576pubmed: 38318243google scholar: lookup
  74. Carr EL, Kelman A, Wu GS, Gopaul R, Senkevitch E, Aghvanyan A, Turay AM, Frauwirth KA. Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.. J. Immunol. 2010;185:1037–1044.
    doi: 10.4049/jimmunol.0903586pmc: PMC2897897pubmed: 20554958google scholar: lookup
  75. Hammami I, Chen J, Bronte V, DeCrescenzo G, Jolicoeur M. L-glutamine is a key parameter in the immunosuppression phenomenon.. Biochem. Biophys. Res. Commun. 2012;425:724–729.
    doi: 10.1016/j.bbrc.2012.07.139pubmed: 22885179google scholar: lookup
  76. Schönfeld P, Wojtczak L. Short- and medium-chain fatty acids in energy metabolism: The cellular perspective.. J. Lipid Res. 2016;57:943–954.
    doi: 10.1194/jlr.R067629pmc: PMC4878196pubmed: 27080715google scholar: lookup
  77. Cucchi D, Camacho-Muñoz D, Certo M, Pucino V, Nicolaou A, Mauro C. Fatty acids—from energy substrates to key regulators of cell survival, proliferation and effector function.. Cell Stress 2019;4:9.
    doi: 10.15698/cst2020.01.209pmc: PMC6946016pubmed: 31922096google scholar: lookup
  78. Zhou X, Zhu X, Zeng H. Fatty acid metabolism in adaptive immunity.. FEBS J. 2021;290:584–599.
    doi: 10.1111/febs.16296pmc: PMC9130345pubmed: 34822226google scholar: lookup
  79. De Oliveira MP, Liesa M. The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival.. Cells 2020;9:2600.
    doi: 10.3390/cells9122600pmc: PMC7761891pubmed: 33291682google scholar: lookup
  80. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB, Polak K, Tondera D, Gounarides J, Yin H. Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma.. Cancer Cell 2012;22:547–560.
    doi: 10.1016/j.ccr.2012.08.014pmc: PMC3479446pubmed: 23079663google scholar: lookup
  81. Liang G, Huang J, Chen J, Wen X, Li R, Xie H, Zhang Z, Chen Z, Chen Y, Xian Z. Fatty Acid Oxidation Promotes Apoptotic Resistance and Proinflammatory Phenotype of CD4(+) Tissue-resident Memory T cells in Crohn’s Disease.. Cell Mol. Gastroenterol. Hepatol. 2024;17:939–964.
    doi: 10.1016/j.jcmgh.2024.02.014pmc: PMC11026735pubmed: 38423357google scholar: lookup
  82. Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee D-H, May C, Wilck N. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.. Immunity 2015;43:817–829.
    doi: 10.1016/j.immuni.2015.09.007pubmed: 26488817google scholar: lookup
  83. Ming S, Tian J, Ma K, Pei C, Li L, Wang Z, Fang Z, Liu M, Dong H, Li W. Oxalate-induced apoptosis through ERS-ROS–NF-κB signalling pathway in renal tubular epithelial cell.. Mol. Med. 2022;28:88.
    doi: 10.1186/s10020-022-00494-5pmc: PMC9347104pubmed: 35922749google scholar: lookup
  84. Murdaca G, Banchero S, Tonacci A, Nencioni A, Monacelli F, Gangemi S. Vitamin D and Folate as Predictors of MMSE in Alzheimer’s Disease: A Machine Learning Analysis.. Diagnostics 2021;11:940.
    doi: 10.3390/diagnostics11060940pmc: PMC8225187pubmed: 34073931google scholar: lookup
  85. Valle MA-O, Russo CA-O, Malaguarnera LA-O. Protective role of vitamin D against oxidative stress in diabetic retinopathy.. Diabetes Metab. Res. Rev. 2021;37:e3447.
    doi: 10.1002/dmrr.3447pubmed: 33760363google scholar: lookup
  86. Wollanke B, Gerhards H, Ackermann K. Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.. Microorganisms 2022;10:387.
    doi: 10.3390/microorganisms10020387pmc: PMC8875353pubmed: 35208842google scholar: lookup
  87. Voelter K, Vial Z, Pot SA, Spiess BM. Leptospiral antibody prevalence and surgical treatment outcome in horses with Equine Recurrent Uveitis (ERU) in Switzerland.. Vet. Ophthalmol. 2020;23:648–658.
    doi: 10.1111/vop.12767pubmed: 32352624google scholar: lookup
  88. McMullen RJ Jr, Fischer BM. Medical and Surgical Management of Equine Recurrent Uveitis.. Vet. Clin. N. Am. Equine Pract. 2017;33:465–481.
    doi: 10.1016/j.cveq.2017.07.003pubmed: 28985983google scholar: lookup
  89. Knych HK. Nonsteroidal Anti-inflammatory Drug Use in Horses.. Vet. Clin. N. Am. Equine Pract. 2017;33:1–15.
    doi: 10.1016/j.cveq.2016.11.001pubmed: 28190614google scholar: lookup
  90. Gilger BC, Michau TM. Equine recurrent uveitis: New methods of management.. Vet. Clin. N. Am. Equine Pract. 2004;20:417–427.
    doi: 10.1016/j.cveq.2004.04.010pubmed: 15271431google scholar: lookup

Citations

This article has been cited 3 times.
  1. Sprenzel CJ, Amann B, Deeg CA, Degroote RL. Glycan Signatures on Neutrophils in an Equine Model for Autoimmune Uveitis. Biomolecules 2025 Oct 12;15(10).
    doi: 10.3390/biom15101444pubmed: 41154673google scholar: lookup
  2. Li J, Hao J, Zhu R, Zhang J, Wang Y, Zhang W, Zhang Y, Gu X, Yin Q, Wu Z, Yang L. Prevalence and Clinical Characteristics of Dark Without Pressure Retinal Changes in a Chinese Hospital-Based Population. Ophthalmol Ther 2025 Oct;14(10):2375-2393.
    doi: 10.1007/s40123-025-01219-7pubmed: 40736870google scholar: lookup
  3. Fleischer AB, Amann B, von Toerne C, Degroote RL, Schmalen A, Weißer T, Hauck SM, Deeg CA. Differential Expression of ARG1 and MRC2 in Retinal Müller Glial Cells During Autoimmune Uveitis. Biomolecules 2025 Feb 14;15(2).
    doi: 10.3390/biom15020288pubmed: 40001591google scholar: lookup
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.